SCHEMBL4603774

SCHEMBL4603774

Cc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.59
ALDH1A1 P00352 12/20 0.59
NPSR1 Q6W5P4 2/20 0.59
GFER P55789 1/20 0.59
KMT2A Q03164 14/20 0.57
MEN1 O00255 12/20 0.57
POLB P06746 7/20 0.57
HPGD P15428 5/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
PKM P14618 6/20 0.54
L3MBTL1 Q9Y468 3/20 0.54
MAPK1 P28482 2/20 0.54
CTDSP1 Q9GZU7 1/20 0.54
KDM4E B2RXH2 3/20 0.54
LMNA P02545 3/20 0.54
HTT P42858 1/20 0.54
TDP1 Q9NUW8 1/20 0.53
GAA P10253 1/20 0.50
THRB P10828 3/20 0.48
GPR55 Q9Y2T6 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19652009 0.75 MAPT (0.58) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL12963896 0.74 KMT2A (0.78) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL8190455 0.73 MAPT (0.66) MAPTALDH1A1NPSR1KMT2AMEN1
SCHEMBL8191326 0.73 MAPT (0.66) MAPTALDH1A1NPSR1KMT2AMEN1
SCHEMBL8190456 0.73 MAPT (0.66) MAPTALDH1A1NPSR1KMT2AMEN1
SCHEMBL4604008 0.72 MAPT (0.57) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL46546 0.72 MAPT (0.57) MAPTALDH1A1NPSR1KMT2AMEN1
SCHEMBL13587009 0.71 ALDH1A1 (0.72) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL17717968 0.71 CA12 (0.71) MAPTALDH1A1KMT2AMEN1PKM
SCHEMBL11908274 0.70 KMT2A (0.63) MAPTALDH1A1NPSR1GFERKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269252-A1 Use of Compounds Derived From Pyrimidinetrione as Acetyl Cholinesterase Inhibitors, Compositions Containing Said Derivatives, and the Uses Thereof CENTRAL NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2008-10-30 US claimed
EP-1845781-B1 USE OF COMPOUNDS DERIVED FROM PYRIMIDINETRIONE AS ACETYL CHOLINESTERASE INHIBITORS, COMPOSITIONS CONTAINING SAID DERIVATIVES, AND THE USES THEREOF CENTRE NAT RECH SCIENT (FR) 2008-07-09 EP claimed
US-8309556-B2 Insecticides, neurodegenerative diseases; Alzheimer's disease CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-11-13 US disclosed
US-20080269252-A1 Use of Compounds Derived From Pyrimidinetrione as Acetyl Cholinesterase Inhibitors, Compositions Containing Said Derivatives, and the Uses Thereof CENTRAL NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2008-10-30 US disclosed
EP-1845781-B1 USE OF COMPOUNDS DERIVED FROM PYRIMIDINETRIONE AS ACETYL CHOLINESTERASE INHIBITORS, COMPOSITIONS CONTAINING SAID DERIVATIVES, AND THE USES THEREOF CENTRE NAT RECH SCIENT (FR) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269252-A1 Use of Compounds Derived From Pyrimidinetrione as Acetyl Cholinesterase Inhibitors, Compositions Containing Said Derivatives, and the Uses Thereof ACHE, BCHE, DPYD MAPT 993/4885ALDH1A1 198/4885NPSR1 2658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.